{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:39Z","timestamp":1793293119257,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00109-020-01885-z","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T19:02:16Z","timestamp":1581188536000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington\u2019s disease"],"prefix":"10.1007","volume":"98","author":[{"given":"Efthalia","family":"Angelopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yam Nath","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-0618","authenticated-orcid":false,"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"1885_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25:24\u201334","journal-title":"Eur J Neurol"},{"key":"1885_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398","journal-title":"Lancet Neurol"},{"key":"1885_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12035-015-9662-8","volume":"54","author":"Y-M Sun","year":"2017","unstructured":"Sun Y-M, Zhang Y-B, Wu Z-Y (2017) Huntington\u2019s disease: relationship between phenotype and genotype. Mol Neurobiol 54:342\u2013348","journal-title":"Mol Neurobiol"},{"key":"1885_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40","journal-title":"Orphanet J Rare Dis"},{"key":"1885_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3727\/096368914X678454","volume":"23","author":"H-C Fan","year":"2014","unstructured":"Fan H-C, Ho L-I, Chi C-S, Chen S-J, Peng G-S, Chan T-M, Lin S-Z, Harn H-J (2014) Polyglutamine (PolyQ) diseases: genetics to treatments. Cell Transplant 23:441\u2013458","journal-title":"Cell Transplant"},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1134\/S0006297918090043","volume":"83","author":"S Illarioshkin","year":"2018","unstructured":"Illarioshkin S, Klyushnikov S, Vigont V, Seliverstov YA, Kaznacheyeva E (2018) Molecular pathogenesis in Huntington\u2019s disease. Biochem Mosc 83:1030\u20131039","journal-title":"Biochem Mosc"},{"key":"1885_CR7","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H et al (2019) Targeting Huntingtin expression in patients with Huntington\u2019s disease. N Engl J Med 380:2307\u20132316","journal-title":"N Engl J Med"},{"key":"1885_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, X-g F, Yan Z (2014) HMGB1 in health and disease. Mol Asp Med 40:1\u2013116","journal-title":"Mol Asp Med"},{"key":"1885_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.4161\/auto.7.8.15704","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang R, Livesey KM, Zeh I, Herbert J, Lotze MT, Tang D (2011) HMGB1 as an autophagy sensor in oxidative stress. Autophagy 7:904\u2013906","journal-title":"Autophagy"},{"key":"1885_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910\u2013926","journal-title":"Neuron"},{"key":"1885_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JHD-150169","volume":"4","author":"K Correia","year":"2015","unstructured":"Correia K, Harold D, Kim K-H, Holmans P, Jones L, Orth M, Myers RH, Kwak S, Wheeler VC, MacDonald ME (2015) The genetic modifiers of motor OnsetAge (GeM MOA) website: genome-wide association analysis for genetic modifiers of Huntington\u2019s disease. Journal of Huntington's disease 4:279\u2013284","journal-title":"Journal of Huntington's disease"},{"key":"1885_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","volume":"16","author":"DJH Moss","year":"2017","unstructured":"Moss DJH, Pardi\u00f1as AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S, Coleman A, Santos RD (2017) Identification of genetic variants associated with Huntington\u2019s disease progression: a genome-wide association study. The Lancet Neurology 16:701\u2013711","journal-title":"The Lancet Neurology"},{"issue":"887\u2013900","key":"1885_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modifiers of Huntington's Disease Consortium. Electronic address ghmhe, Genetic Modifiers of Huntington's Disease C","year":"2019","unstructured":"Genetic Modifiers of Huntington's Disease Consortium. Electronic address ghmhe, Genetic Modifiers of Huntington's Disease C (2019) CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178(887\u2013900):e814. https:\/\/doi.org\/10.1016\/j.cell.2019.06.036","journal-title":"Cell"},{"key":"1885_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153B","author":"DR Langbehn","year":"2010","unstructured":"Langbehn DR, Hayden MR, Paulsen JS, the P-HDIotHSG (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 153B:397\u2013408","journal-title":"American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics"},{"key":"1885_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2202-3-15","volume":"3","author":"H Takano","year":"2002","unstructured":"Takano H, Gusella JF (2002) The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor. BMC Neurosci 3:15","journal-title":"BMC Neurosci"},{"key":"1885_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature25502","volume":"555","author":"Q Guo","year":"2018","unstructured":"Guo Q, Bin H, Cheng J, Seefelder M, Engler T, Pfeifer G, Oeckl P, Otto M, Moser F, Maurer M et al (2018) The cryo-electron microscopy structure of huntingtin. Nature 555:117\u2013120","journal-title":"Nature"},{"key":"1885_CR17","doi-asserted-by":"publisher","first-page":"11655","DOI":"10.1038\/ncomms11655","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Chu H, Lv M, Zhang Z, Qiu S, Liu H, Shen X, Wang W, Cai G (2016) Structure of the intact ATM\/Tel1 kinase. Nat Commun 7:11655","journal-title":"Nat Commun"},{"key":"1885_CR18","doi-asserted-by":"publisher","first-page":"39626","DOI":"10.1074\/jbc.M112.412379","volume":"287","author":"CR Desmond","year":"2012","unstructured":"Desmond CR, Atwal RS, Xia J, Truant R (2012) Identification of a karyopherin beta1\/beta2 proline-tyrosine nuclear localization signal in huntingtin protein. J Biol Chem 287:39626\u201339633","journal-title":"J Biol Chem"},{"key":"1885_CR19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1074\/jbc.RA117.001440","volume":"294","author":"S Son","year":"2019","unstructured":"Son S, Bowie LE, Maiuri T, Hung CL, Desmond CR, Xia J, Truant R (2019) High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry. J Biol Chem 294:1915\u20131923","journal-title":"J Biol Chem"},{"key":"1885_CR20","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1074\/jbc.M112.413575","volume":"288","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Li A, Holmes BB, Marasa JC, Diamond MI (2013) An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem 288:6063\u20136071","journal-title":"J Biol Chem"},{"key":"1885_CR21","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/hmg\/ddw234","volume":"25","author":"LF DiGiovanni","year":"2016","unstructured":"DiGiovanni LF, Mocle AJ, Xia J, Truant R (2016) Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization. Hum Mol Genet 25:3937\u20133945","journal-title":"Hum Mol Genet"},{"key":"1885_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nchembio.582","volume":"7","author":"RS Atwal","year":"2011","unstructured":"Atwal RS, Desmond CR, Caron N, Maiuri T, Xia J, Sipione S, Truant R (2011) Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol 7:453","journal-title":"Nat Chem Biol"},{"key":"1885_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191","journal-title":"Cell"},{"key":"1885_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1189\/jlb.0806540","volume":"81","author":"D Tang","year":"2007","unstructured":"Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, Xiao X (2007) Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 81:741\u2013747","journal-title":"J Leukoc Biol"},{"key":"1885_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.4049\/jimmunol.1202472","volume":"190","author":"HJ Min","year":"2013","unstructured":"Min HJ, Ko EA, Wu J, Kim ES, Kwon MK, Kwak MS, Choi JE, Lee JE, Shin J-S (2013) Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J Immunol 190:1797\u20131806","journal-title":"J Immunol"},{"key":"1885_CR26","first-page":"925","volume":"69","author":"K Fujita","year":"2017","unstructured":"Fujita K, Okazawa H (2017) Molecularly-targeted therapy of spinocerebellar ataxia type 1 by HMGB1. Brain and nerve= Shinkei kenkyu no shinpo 69:925\u2013932","journal-title":"Brain and nerve= Shinkei kenkyu no shinpo"},{"key":"1885_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.mad.2012.01.005","volume":"133","author":"ML Hegde","year":"2012","unstructured":"Hegde ML, Mantha AK, Hazra TK, Bhakat KK, Mitra S, Szczesny B (2012) Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech Ageing Dev 133:157\u2013168","journal-title":"Mech Ageing Dev"},{"key":"1885_CR28","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1885_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383","journal-title":"Nat Genet"},{"key":"1885_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1101\/gad.12.4.462","volume":"12","author":"L Jayaraman","year":"1998","unstructured":"Jayaraman L, Moorthy NC, Murthy KG, Manley JL, Bustin M, Prives C (1998) High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12:462\u2013472","journal-title":"Genes Dev"},{"key":"1885_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1209021","volume":"25","author":"Z Feng","year":"2006","unstructured":"Feng Z, Jin S, Zupnick A, Hoh J, De Stanchina E, Lowe S, Prives C, Levine A (2006) p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25:1","journal-title":"Oncogene"},{"key":"1885_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/hmg\/ddw395","volume":"26","author":"T Maiuri","year":"2016","unstructured":"Maiuri T, Mocle AJ, Hung CL, Xia J, van Roon-Mom WM, Truant R (2016) Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Hum Mol Genet 26:395\u2013406","journal-title":"Hum Mol Genet"},{"key":"1885_CR33","first-page":"268","volume":"6","author":"X-H Lu","year":"2014","unstructured":"Lu X-H, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, Waldvogel H, Greiner E, Osmand A, Elzein K (2014) Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease. Science translational medicine 6:268\u2013178","journal-title":"Science translational medicine"},{"key":"1885_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1126\/science.1192912","volume":"330","author":"Z Guo","year":"2010","unstructured":"Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT (2010) ATM activation by oxidative stress. Science 330:517\u2013521","journal-title":"Science"},{"key":"1885_CR35","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1073\/pnas.1416031112","volume":"112","author":"SV Khoronenkova","year":"2015","unstructured":"Khoronenkova SV, Dianov GL (2015) ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc Natl Acad Sci U S A 112:3997\u20134002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1885_CR36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.280.5366.1089","volume":"280","author":"K-H Herzog","year":"1998","unstructured":"Herzog K-H, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089\u20131091","journal-title":"Science"},{"key":"1885_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0896-6273(04)00017-0","volume":"41","author":"II Kruman","year":"2004","unstructured":"Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549\u2013561","journal-title":"Neuron"},{"key":"1885_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","volume":"920","author":"A Sharma","year":"2012","unstructured":"Sharma A, Singh K, Almasan A (2012) Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 920:613\u2013626","journal-title":"Methods Mol Biol"},{"key":"1885_CR39","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/hmg\/ddg242","volume":"12","author":"P Giuliano","year":"2003","unstructured":"Giuliano P, de Cristofaro T, Affaitati A, Pizzulo GM, Feliciello A, Criscuolo C, De Michele G, Filla A, Avvedimento EV, Varrone S (2003) DNA damage induced by polyglutamine-expanded proteins. Hum Mol Genet 12:2301\u20132309","journal-title":"Hum Mol Genet"},{"key":"1885_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200905138","volume":"189","author":"Y Enokido","year":"2010","unstructured":"Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H, Sone M, Foulle R, Sawada H, Ishiguro H (2010) Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol 189:425\u2013443","journal-title":"J Cell Biol"},{"key":"1885_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"B-I Bae","year":"2005","unstructured":"Bae B-I, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47:29\u201341","journal-title":"Neuron"},{"key":"1885_CR42","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/hmg\/ddu609","volume":"24","author":"AM Tidball","year":"2014","unstructured":"Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD, Aschner M, Bowman AB (2014) A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Hum Mol Genet 24:1929\u20131944","journal-title":"Hum Mol Genet"},{"key":"1885_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ncb1553","volume":"9","author":"M-L Qi","year":"2007","unstructured":"Qi M-L, Tagawa K, Enokido Y, Yoshimura N, Y-i W, Watase K, S-i I, Kanazawa I, Botas J, Saitoe M (2007) Proteome analysis of soluble nuclear proteins reveals that HMGB1\/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol 9:402","journal-title":"Nat Cell Biol"},{"key":"1885_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2008.08.108","volume":"376","author":"Y Enokido","year":"2008","unstructured":"Enokido Y, Yoshitake A, Ito H, Okazawa H (2008) Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. Biochem Biophys Res Commun 376:128\u2013133","journal-title":"Biochem Biophys Res Commun"},{"key":"1885_CR45","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1021\/bi300410d","volume":"51","author":"A-V Goula","year":"2012","unstructured":"Goula A-V, Pearson CE, Della Maria J, Trottier Y, Tomkinson AE, Wilson DM III, Merienne K (2012) The nucleotide sequence, DNA damage location, and protein stoichiometry influence the base excision repair outcome at CAG\/CTG repeats. Biochemistry 51:3919\u20133932","journal-title":"Biochemistry"},{"key":"1885_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.dnarep.2016.10.006","volume":"48","author":"JM Beaver","year":"2016","unstructured":"Beaver JM, Lai Y, Rolle SJ, Liu Y (2016) Proliferating cell nuclear antigen prevents trinucleotide repeat expansions by promoting repeat deletion and hairpin removal. DNA repair 48:17\u201329","journal-title":"DNA repair"},{"key":"1885_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447:447","journal-title":"Nature"},{"key":"1885_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.279.5352.853","volume":"279","author":"CH Freudenreich","year":"1998","unstructured":"Freudenreich CH, Kantrow SM, Zakian VA (1998) Expansion and length-dependent fragility of CTG repeats in yeast. Science 279:853\u2013856","journal-title":"Science"},{"key":"1885_CR49","doi-asserted-by":"publisher","first-page":"e1000749","DOI":"10.1371\/journal.pgen.1000749","volume":"5","author":"A-V Goula","year":"2009","unstructured":"Goula A-V, Berquist BR, Wilson DM III, Wheeler VC, Trottier Y, Merienne K (2009) Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet 5:e1000749","journal-title":"PLoS Genet"},{"key":"1885_CR50","doi-asserted-by":"publisher","first-page":"28352","DOI":"10.1074\/jbc.M109.050286","volume":"284","author":"Y Liu","year":"2009","unstructured":"Liu Y, Prasad R, Beard WA, Hou EW, Horton JK, McMurray CT, Wilson SH (2009) Coordination between polymerase \u03b2 and FEN1 can modulate CAG repeat expansion. J Biol Chem 284:28352\u201328366","journal-title":"J Biol Chem"},{"key":"1885_CR51","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson CE, Edamura KN, Cleary JD (2005) Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6:729","journal-title":"Nat Rev Genet"},{"key":"1885_CR52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/bi301369b","volume":"52","author":"MM Slean","year":"2013","unstructured":"Slean MM, Reddy K, Wu B, Nichol Edamura K, Kekis M, Nelissen FH, Aspers RL, Tessari M, Sch\u00e4rer OD, Wijmenga SS (2013) Interconverting conformations of slipped-DNA junctions formed by trinucleotide repeats affect repair outcome. Biochemistry 52:773\u2013785","journal-title":"Biochemistry"},{"key":"1885_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate M, Finkbeiner S (2012) Protein aggregates in Huntington\u2019s disease. Exp Neurol 238:1\u201311","journal-title":"Exp Neurol"},{"key":"1885_CR54","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D, Chai Y, Paulson H, Sobue G (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9:2197\u20132202","journal-title":"Hum Mol Genet"},{"key":"1885_CR55","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.1530212100","volume":"100","author":"KM Donaldson","year":"2003","unstructured":"Donaldson KM, Li W, Ching KA, Batalov S, Tsai C-C, Joazeiro CA (2003) Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci 100:8892\u20138897","journal-title":"Proc Natl Acad Sci"},{"key":"1885_CR56","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1074\/jbc.M110.156521","volume":"286","author":"A Bertoni","year":"2011","unstructured":"Bertoni A, Giuliano P, Galgani M, Rotoli D, Ulianich L, Adornetto A, Santillo MR, Porcellini A, Avvedimento VE (2011) Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins. J Biol Chem 286:4727\u20134741","journal-title":"J Biol Chem"},{"key":"1885_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jnc.13178","volume":"134","author":"J Kim","year":"2015","unstructured":"Kim J, Waldvogel HJ, Faull RL, Curtis MA, Nicholson LF (2015) The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington\u2019s disease. J Neurochem 134:927\u2013942","journal-title":"J Neurochem"},{"key":"1885_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2004.05.052","volume":"1018","author":"L Ma","year":"2004","unstructured":"Ma L, Nicholson LF (2004) Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Res 1018:10\u201317","journal-title":"Brain Res"},{"key":"1885_CR59","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","volume":"24","author":"A Khoshnan","year":"2004","unstructured":"Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, Patterson PH (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24:7999\u20138008","journal-title":"J Neurosci"},{"key":"1885_CR60","unstructured":"Pedrazzi M, Melloni E, Sparatore B (2010) Selective pro-inflammatory activation of astrocytes by high mobility group box 1 protein signaling new insights to neuroimmune biology. Elsevier, pp 53\u201372"},{"key":"1885_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.brainresbull.2011.01.009","volume":"87","author":"S Anzilotti","year":"2012","unstructured":"Anzilotti S, Giamp\u00e0 C, Laurenti D, Perrone L, Bernardi G, Melone MA, Fusco FR (2012) Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6\/2 mouse model of Huntington\u2019s disease. Brain Res Bull 87:350\u2013358","journal-title":"Brain Res Bull"},{"key":"1885_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuroscience.2018.03.042","volume":"380","author":"D Shi","year":"2018","unstructured":"Shi D, Chang JW, Choi J, Connor B, O'carroll SJ, Nicholson LF, Kim JH (2018) Receptor for advanced glycation end products (RAGE) is expressed predominantly in medium spiny neurons of tgHD rat striatum. Neuroscience 380:146\u2013151","journal-title":"Neuroscience"},{"key":"1885_CR63","doi-asserted-by":"publisher","first-page":"e00508","DOI":"10.1016\/j.heliyon.2018.e00508","volume":"4","author":"K Griffioen","year":"2018","unstructured":"Griffioen K, Mattson MP, Okun E (2018) Deficiency of toll-like receptors 2, 3 or 4 extends life expectancy in Huntington\u2019s disease mice. Heliyon 4:e00508","journal-title":"Heliyon"},{"key":"1885_CR64","doi-asserted-by":"publisher","first-page":"e0203837","DOI":"10.1371\/journal.pone.0203837","volume":"13","author":"H El-Abhar","year":"2018","unstructured":"El-Abhar H, El Fattah MAA, Wadie W, El-Tanbouly DM (2018) Cilostazol disrupts TLR-4, Akt\/GSK-3\u03b2\/CREB, and IL-6\/JAK-2\/STAT-3\/SOCS-3 crosstalk in a rat model of Huntington's disease. PLoS One 13:e0203837","journal-title":"PLoS One"},{"key":"1885_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DD Martin","year":"2015","unstructured":"Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR (2015) Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci 38:26\u201335","journal-title":"Trends Neurosci"},{"key":"1885_CR66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15252\/emmm.201404392","volume":"7","author":"H Ito","year":"2015","unstructured":"Ito H, Fujita K, Tagawa K, Chen X, Homma H, Sasabe T, Shimizu J, Shimizu S, Tamura T, Si M (2015) HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice. EMBO molecular medicine 7:78\u2013101","journal-title":"EMBO molecular medicine"},{"key":"1885_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115809","volume":"9","author":"L-C Lee","year":"2014","unstructured":"Lee L-C, Chen C-M, Wang P-R, Su M-T, Lee-Chen G-J, Chang C-Y (2014) Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis. PLoS One 9:e115809","journal-title":"PLoS One"},{"key":"1885_CR68","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","volume":"190","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Livesey KM, Cheh C-W, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ (2010) Endogenous HMGB1 regulates autophagy. J Cell Biol 190:881\u2013892","journal-title":"J Cell Biol"},{"key":"1885_CR69","doi-asserted-by":"crossref","unstructured":"Kalathur RKR, Giner-Lamia J, Machado S, Barata T, Ayasolla KR, Futschik ME (2015) The unfolded protein response and its potential role in Huntington\u2019s disease elucidated by a systems biology approach. F1000Research 4","DOI":"10.12688\/f1000research.6358.1"},{"key":"1885_CR70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/156652408784221324","volume":"8","author":"S Matus","year":"2008","unstructured":"Matus S, Lisbona F, Torres M, Le\u00f3n C, Thielen P, Hetz C (2008) The stress rheostat: an interplay between the unfolded protein response (UPR) and autophagy in neurodegeneration. Curr Mol Med 8:157\u2013172","journal-title":"Curr Mol Med"},{"key":"1885_CR71","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/10338","volume":"22","author":"S Calogero","year":"1999","unstructured":"Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, Bianchi ME (1999) The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 22:276\u2013280","journal-title":"Nat Genet"},{"key":"1885_CR72","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/dvdy.22598","volume":"240","author":"J Itou","year":"2011","unstructured":"Itou J, Taniguchi N, Oishi I, Kawakami H, Lotz M, Kawakami Y (2011) HMGB factors are required for posterior digit development through integrating signaling pathway activities. Developmental dynamics : an official publication of the American Association of Anatomists 240:1151\u20131162","journal-title":"Developmental dynamics : an official publication of the American Association of Anatomists"},{"key":"1885_CR73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.intimp.2011.01.005","volume":"11","author":"Q Lin","year":"2011","unstructured":"Lin Q, Fang J, Fang D, Li B, Zhou H, Su SB (2011) Production of recombinant human HMGB1 and anti-HMGB1 rabbit serum. Int Immunopharmacol 11:646\u2013651","journal-title":"Int Immunopharmacol"},{"key":"1885_CR74","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington\u2019s disease. Nat Rev Neurosci 14:708\u2013721","journal-title":"Nat Rev Neurosci"},{"key":"1885_CR75","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/WNL.0b013e31826e9a5d","volume":"79","author":"TC Hadzi","year":"2012","unstructured":"Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH (2012) Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology 79:1708\u20131715","journal-title":"Neurology"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01885-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-020-01885-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01885-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T03:12:00Z","timestamp":1612840320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-020-01885-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01885-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}